Raquel Romao

Santo Antonio De Felheiros, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast Cancer.

NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast Cancer.

Journal: Cureus

Published: February 06, 2026

Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer-Spanish Lung Cancer Group Expert Consensus Statement.

Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer-Spanish Lung Cancer Group Expert Consensus Statement.

Journal: JTO clinical and research reports

Published: September 23, 2025

Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population.

Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population.

Journal: Cancers

Published: April 27, 2025

Correction: Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2- breast cancer.

Correction: Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2- breast cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 18, 2025

LUDICAS: sexual dysfunction in patients with lung cancer, a multicenter cross-sectional study.

LUDICAS: sexual dysfunction in patients with lung cancer, a multicenter cross-sectional study.

Journal: ESMO open

Published: January 16, 2025

Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2- breast cancer.

Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2- breast cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 25, 2024

Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center.

Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center.

Journal: Current oncology (Toronto, Ont.)

Published: January 05, 2024

Immunotherapy in Elderly Patients-Single-Center Experience.

Immunotherapy in Elderly Patients-Single-Center Experience.

Journal: Cancers

Published: December 06, 2023

Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients' Survival: Single Center Experience and Literature Review.

Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients' Survival: Single Center Experience and Literature Review.

Journal: Cancers

Published: December 12, 2022

Chemotherapy: A partnership with immunotherapy in non-small cell lung cancer.

Chemotherapy: A partnership with immunotherapy in non-small cell lung cancer.

Journal: Thoracic cancer

Published: November 16, 2022

Best Supportive Care of the Patient with Oesophageal Cancer.

Best Supportive Care of the Patient with Oesophageal Cancer.

Journal: Cancers

Published: October 17, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026